Your browser doesn't support javascript.
loading
Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia.
Kaiyrzhanov, Rauan; Ortigoza-Escobar, Juan Darío; Stringer, Brett W; Ganieva, Manizha; Gowda, Vykuntaraju K; Srinivasan, Varunvenkat M; Macaya, Alfons; Laner, Andreas; Onbool, Enas; Al-Shammari, Randa; Al-Owain, Mohammed; Deconinck, Nicolas; Vilain, Catheline; Dontaine, Pauline; Self, Eleanor; Akram, Rabia; Hussain, Ghulam; Baig, Shahid Mahmood; Iqbal, Javed; Salpietro, Vincenzo; Neshatdoust, Maedeh; Kasiri, Mahboubeh; Yesil, Gozde; Uygur, Turkan; Pysden, Karen; Berry, Ian R; Alves, Cesar Augusto; Giacomotto, Jean; Houlden, Henry; Maroofian, Reza.
Afiliação
  • Kaiyrzhanov R; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Ortigoza-Escobar JD; U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Stringer BW; Movement Disorders Unit, Pediatric Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Ganieva M; European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain.
  • Gowda VK; Griffith Institute for Drug Discovery, Centre for Cellular Phenomics, School of Environment and Science Griffith University, Brisbane, Queensland, Australia.
  • Srinivasan VM; Avicenna Tajik State Medical University, Department of Neurology and Medical Genetics, Dushanbe, Tajikistan.
  • Macaya A; Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, India.
  • Laner A; Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, India.
  • Onbool E; European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain.
  • Al-Shammari R; Department of Paediatric Neurology, University Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Al-Owain M; MGZ - Medical Genetics Centre, Munich, Germany.
  • Deconinck N; Neurology department, King Abdulaziz Specialist Hospital, Skaka Aljouf, Saudi Arabia.
  • Vilain C; Department of Medical Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Dontaine P; Department of Medical Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Self E; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Akram R; Centre de Référence des Maladies Neuromusculaires et Service de Neurologie Pédiatrique, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Hussain G; Department of Genetics, Hôpital Universitaire Reine Fabiola (HUDERF); Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Baig SM; Centre de Référence des Maladies Neuromusculaires et Service de Neurologie Pédiatrique, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Iqbal J; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Salpietro V; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Neshatdoust M; Neurochemical biology and Genetics Laboratory (NGL), Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, Pakistan.
  • Kasiri M; Neurochemical biology and Genetics Laboratory (NGL), Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, Pakistan.
  • Yesil G; Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, Faisalabad, Pakistan.
  • Uygur T; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
  • Pysden K; Department of Neurology, Allied Hospital, Faisalabad Medical University, Faisalabad, Pakistan.
  • Berry IR; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Alves CA; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
  • Giacomotto J; School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Houlden H; Department of Medical Genetics, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Maroofian R; Department of Pediatric Neurology, Bezmialem Vakif University, Istanbul, Turkey.
Mov Disord ; 39(6): 983-995, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38581205
ABSTRACT

BACKGROUND:

Based on a limited number of reported families, biallelic CA8 variants have currently been associated with a recessive neurological disorder named, cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CAMRQ-3).

OBJECTIVES:

We aim to comprehensively investigate CA8-related disorders (CA8-RD) by reviewing existing literature and exploring neurological, neuroradiological, and molecular observations in a cohort of newly identified patients.

METHODS:

We analyzed the phenotype of 27 affected individuals from 14 families with biallelic CA8 variants (including data from 15 newly identified patients from eight families), ages 4 to 35 years. Clinical, genetic, and radiological assessments were performed, and zebrafish models with ca8 knockout were used for functional analysis.

RESULTS:

Patients exhibited varying degrees of neurodevelopmental disorders (NDD), along with predominantly progressive cerebellar ataxia and pyramidal signs and variable bradykinesia, dystonia, and sensory impairment. Quadrupedal gait was present in only 10 of 27 patients. Progressive selective cerebellar atrophy, predominantly affecting the superior vermis, was a key diagnostic finding in all patients. Seven novel homozygous CA8 variants were identified. Zebrafish models demonstrated impaired early neurodevelopment and motor behavior on ca8 knockout.

CONCLUSION:

Our comprehensive analysis of phenotypic features indicates that CA8-RD exhibits a wide range of clinical manifestations, setting it apart from other subtypes within the category of CAMRQ. CA8-RD is characterized by cerebellar atrophy and should be recognized as part of the autosomal-recessive cerebellar ataxias associated with NDD. Notably, the presence of progressive superior vermis atrophy serves as a valuable diagnostic indicator. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Ataxia Cerebelar Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peixe-Zebra / Ataxia Cerebelar Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article